Matsumoto M and Miwa M |
Platelet-activating factor-binding protein in human serum. |
1985 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:3004155
|
Terashita Z et al. |
Beneficial effects of (RS)-2-methoxy-3-(octadecylcarbamoyloxy)propyl 2-(3-thiazolio)ethyl phosphate, a specific PAF antagonist, in endotoxin and anaphylactic shock. |
1985 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:3004156
|
Barnes JL and Venkatachalam MA |
The role of platelets and polycationic mediators in glomerular vascular injury. |
1985 |
Semin. Nephrol. |
pmid:2957770
|
Leid RW and Potter KA |
Inflammation and mediators of lung injury. |
1985 |
Vet. Clin. North Am. Food Anim. Pract. |
pmid:3907779
|
Shukla SD |
Platelet activating factor-stimulated formation of inositol triphosphate in platelets and its regulation by various agents including Ca2+, indomethacin, CV-3988, and forskolin. |
1985 |
Arch. Biochem. Biophys. |
pmid:3875314
|
Roubin R and Benveniste J |
Formation of prostaglandins, leukotrienes and paf-acether by macrophages. |
1985 |
Comp. Immunol. Microbiol. Infect. Dis. |
pmid:3910339
|
Billah MM et al. |
Platelet-activating factor metabolism in human amnion and the responses of this tissue to extracellular platelet-activating factor. |
1985 |
Prostaglandins |
pmid:3936121
|
Wasserman SI |
Mast cell mediators in the blood of patients with asthma. |
1985 |
Chest |
pmid:3880526
|
Halonen M et al. |
Participation of platelets in the physiologic alterations of the AGEPC response and of IgE anaphylaxis in the rabbit. Effects of PGI2 inhibition of platelet function. |
1985 |
Am. Rev. Respir. Dis. |
pmid:3881060
|
Sybertz EJ et al. |
Cardiac, coronary and peripheral vascular effects of acetyl glyceryl ether phosphoryl choline in the anesthetized dog. |
1985 |
J. Pharmacol. Exp. Ther. |
pmid:3917504
|
Harlan JM |
Leukocyte-endothelial interactions. |
1985 |
Blood |
pmid:3918593
|
McKean ML and Silver MJ |
Phospholipid biosynthesis in human platelets. The acylation of lyso-platelet-activating factor. |
1985 |
Biochem. J. |
pmid:3919710
|
Archer CB et al. |
Actions of disodium cromoglycate (DSCG) on human skin responses to histamine, codeine and Paf-acether. |
1985 |
Agents Actions |
pmid:3923788
|
Malone B et al. |
Inactivation of platelet activating factor by rabbit platelets. Lyso-platelet activating factor as a key intermediate with phosphatidylcholine as the source of arachidonic acid in its conversion to a tetraenoic acylated product. |
1985 |
J. Biol. Chem. |
pmid:3918041
|
Steiner M et al. |
Biological activity of platelet activating factor-amidophosphonate (PAF-AP), a novel phosphonolipid selective inhibitor of platelet activating factor (PAF). |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:3936503
|
Shen TY et al. |
The isolation and characterization of kadsurenone from haifenteng (Piper futokadsura) as an orally active specific receptor antagonist of platelet-activating factor. |
1985 |
Int J Tissue React |
pmid:2997065
|
Sánchez Crespo M et al. |
Synthesis of platelet-activating factor from human polymorphonuclear leukocytes: regulation and pharmacological approaches. |
1985 |
Int J Tissue React |
pmid:2997066
|
Proll MA et al. |
Phosphatidate and monooleylphosphatidate inhibition of fibroblast adenylate cyclase is mediated by the inhibitory coupling protein, Ni. |
1985 |
Mol. Pharmacol. |
pmid:2997592
|
MacIntyre DE et al. |
Endogenous and pharmacological mechanisms for the regulation of human platelet cytosolic free Ca2+. |
1985 |
Nouv Rev Fr Hematol |
pmid:2997706
|
Lachachi H et al. |
Inhibition of transmembrane movement and metabolism of platelet activating factor (PAF-acether) by a specific antagonist, BN 52021. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:2998370
|
Hwang SB et al. |
trans-2,5-Bis-(3,4,5-trimethoxyphenyl)tetrahydrofuran. An orally active specific and competitive receptor antagonist of platelet activating factor. |
1985 |
J. Biol. Chem. |
pmid:2999126
|
Camussi G et al. |
The role of platelet-activating factor in experimental immune complex pathology. |
1985 |
Int J Tissue React |
pmid:2932406
|
Benveniste J |
Biosynthesis and function of PAF-acether (platelet-activating factor). |
1985 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2936197
|
Tamargo J et al. |
Electrophysiological effects of platelet-activating factor (PAF-acether) in guinea-pig papillary muscles. |
1985 |
Eur. J. Pharmacol. |
pmid:3996472
|
Terashita Z et al. |
Is platelet activating factor (PAF) a mediator of endotoxin shock? |
1985 |
Eur. J. Pharmacol. |
pmid:3996473
|
Brain SD and Williams TJ |
Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability. |
1985 |
Br. J. Pharmacol. |
pmid:2416378
|
Touqui L et al. |
1-O-alkyl-2-acyl-sn-glycero-3-phosphorylcholine is the precursor of platelet-activating factor in stimulated rabbit platelets. Evidence for an alkylacetyl-glycerophosphorylcholine cycle. |
1985 |
Biochim. Biophys. Acta |
pmid:3967037
|
Weber N and Benning H |
Ether glycerolipids: novel substrates for studying specificity of enzymes involved in glycerolipid biosynthesis in higher plants. |
1985 |
Eur. J. Biochem. |
pmid:3967662
|
O'Neill C |
Partial characterization of the embryo-derived platelet-activating factor in mice. |
1985 |
J. Reprod. Fertil. |
pmid:4067921
|
Mallet AI and Cunningham FM |
Structural identification of platelet activating factor in psoriatic scale. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:3970690
|
Valone FH |
Inhibition of binding of the platelet-activating factor AGEPC to platelets by the AGEPC analog rac-3-(N-n-octadecylcarbamoyloxy)-2-methoxypropyl 2-thiazolioethyl phosphate (CV-3988). |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:3970703
|
Camussi G and Brentjens JR |
Inhalation of horseradish peroxidase by rabbits with specific IgE antibodies results in release into the circulation of platelet-activating factor and in lung lesions. |
1985 |
Clin. Immunol. Immunopathol. |
pmid:3971603
|
Darius H et al. |
Beneficial effects of a new potent and specific thromboxane receptor antagonist (SQ-29,548) in vitro and in vivo. |
1985 |
J. Pharmacol. Exp. Ther. |
pmid:2997428
|
Chesney CM et al. |
Desensitization of human platelets by platelet activating factor. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:3977920
|
Nakayama R et al. |
Generation of acetyl glyceryl ether phosphorylcholine from the rat skin and muscle tissues stimulated by moxibustion. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:3977939
|
Archer CB et al. |
Accumulation of inflammatory cells in response to intracutaneous platelet activating factor (Paf-acether) in man. |
1985 |
Br. J. Dermatol. |
pmid:3978036
|
Gerdin B et al. |
Permeability-increasing ability of PAF-acether in rat skin. |
1985 |
Inflammation |
pmid:3980073
|
Emeis JJ and Kluft C |
PAF-acether-induced release of tissue-type plasminogen activator from vessel walls. |
1985 |
Blood |
pmid:3924144
|
Ardaillou N et al. |
Vasoconstrictor-evoked prostaglandin synthesis in cultured human mesangial cells. |
1985 |
Am. J. Physiol. |
pmid:3918460
|
Lee TC |
Biosynthesis of platelet activating factor. Substrate specificity of 1-alkyl-2-lyso-sn-glycero-3-phosphocholine:acetyl-CoA acetyltransferase in rat spleen microsomes. |
1985 |
J. Biol. Chem. |
pmid:4030776
|
Wissner A et al. |
Analogues of platelet activating factor (PAF). 2. Some modifications of the glycerine backbone. |
1985 |
J. Med. Chem. |
pmid:4032422
|
Pritchard PH et al. |
The degradation of platelet-activating factor in the plasma of a patient with familial high density lipoprotein deficiency (Tangier disease). |
1985 |
Blood |
pmid:4063532
|
Wissner A et al. |
Analogues of platelet activating factor. 3. Replacement of the phosphate moiety with a sulfonylbismethylene group. |
1985 |
J. Med. Chem. |
pmid:4032438
|
Wimberly HC et al. |
Functional and biochemical characterization of immunologically derived equine platelet-activating factor. |
1985 |
Vet. Pathol. |
pmid:4035942
|
MacIntyre DE et al. |
Tumour-promoting phorbol esters inhibit agonist-induced phosphatidate formation and Ca2+ flux in human platelets. |
1985 |
FEBS Lett. |
pmid:2981715
|
Ludwig JC et al. |
Modulation of platelet-activating factor (PAF) synthesis and release from human polymorphonuclear leukocytes (PMN): role of extracellular albumin. |
1985 |
Arch. Biochem. Biophys. |
pmid:4037794
|
Surles JR et al. |
Facile synthesis of platelet-activating factor and racemic analogues containing unsaturation in the sn-1-alkyl chain. |
1985 |
J. Med. Chem. |
pmid:4038418
|
Aul C et al. |
[Thrombotic thrombocytopenic purpura]. |
1985 |
Klin. Wochenschr. |
pmid:4038757
|
Hanahan DJ et al. |
A novel approach to structure proof of glyceryl ether-containing glycerophospholipids. Base-catalyzed methanolysis of platelet-activating factor (AGEPC) at 60 degrees C. |
1985 |
J. Lipid Res. |
pmid:4067422
|
Atkins JN |
Platelet-aggregating factor in thrombotic thrombocytopenic purpura. |
1985 |
Ann. Intern. Med. |
pmid:4038861
|
Klöcking HP et al. |
Release of tissue-type plasminogen activator by platelet-activating factor. |
1985 |
Thromb. Res. |
pmid:4040278
|
Pedersen AK and FitzGerald GA |
Cyclooxygenase inhibition, platelet function, and metabolite formation during chronic sulfinpyrazone dosing. |
1985 |
Clin. Pharmacol. Ther. |
pmid:3917387
|
McManus LM and Pinckard RN |
Kinetics of acetyl glyceryl ether phosphorylcholine (AGEPC)-induced acute lung alterations in the rabbit. |
1985 |
Am. J. Pathol. |
pmid:4050977
|
Sugiura T et al. |
Transacylation of 1-O-alkyl-SN-glycero-3-phosphocholine (lyso platelet-activating factor) and 1-O-alkenyl-SN-glycero-3-phosphoethanolamine with docosahexaenoic acid (22:6 omega 3). |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:2935146
|
Oda M et al. |
Molecular species of platelet-activating factor generated by human neutrophils challenged with ionophore A23187. |
1985 |
J. Immunol. |
pmid:3917470
|
Bergelson LD et al. |
Influence of platelet activation factor and prostaglandins on cholesterol esterification in human plasma. |
1985 |
FEBS Lett. |
pmid:4043408
|
Kilpatrick JM and Virella G |
Inhibition of platelet-activating factor by rabbit C-reactive protein. |
1985 |
Clin. Immunol. Immunopathol. |
pmid:4042435
|
Monnens L et al. |
Platelet aggregating factor in the epidemic form of hemolytic-uremic syndrome in childhood. |
1985 |
Clin. Nephrol. |
pmid:4042442
|
Pirotzky E et al. |
Vascular permeability induced by Paf-acether (platelet-activating factor) in the isolated perfused rat kidney. |
1985 |
Agents Actions |
pmid:4003192
|
Page CP et al. |
Platelet activating factor (Paf-acether) may account for late-onset reactions to allergen inhalation. |
1985 |
Agents Actions |
pmid:4003195
|
Page CP et al. |
Suppression of Paf-acether responses: an anti-inflammatory effect of anti-asthma drugs. |
1985 |
Agents Actions |
pmid:4003196
|
Spicer BA et al. |
An investigation of the involvement of platelet activating factor in the non-histamine immediate hypersensitivity reaction in the rat peritoneal cavity. |
1985 |
Agents Actions |
pmid:4003197
|
Sandler RM et al. |
Heparin-induced thrombocytopenia and thrombosis: detection and specificity of a platelet-aggregating IgG. |
1985 |
Am. J. Clin. Pathol. |
pmid:4003343
|
Tencé M et al. |
Ether-phospholipid composition in neutrophils and platelets. |
1985 |
Thromb. Res. |
pmid:4024039
|
Oda M et al. |
Production of platelet-activating factor by washed rabbit platelets. |
1985 |
J. Lipid Res. |
pmid:3934305
|
Tan EL and Snyder F |
Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) by capillary endothelial cells isolated from rat epididymal adipose tissue. |
1985 |
Thromb. Res. |
pmid:4024051
|
Vigo C |
Effect of C-reactive protein on platelet-activating factor-induced platelet aggregation and membrane stabilization. |
1985 |
J. Biol. Chem. |
pmid:3919022
|
Sugiura T and Waku K |
CoA-independent transfer of arachidonic acid from 1,2-diacyl-sn-glycero-3-phosphocholine to 1-O-alkyl-sn-glycero-3-phosphocholine (lyso platelet-activating factor) by macrophage microsomes. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:3919727
|
O'Flaherty JT |
Neutrophil degranulation: evidence pertaining to its mediation by the combined effects of leukotriene B4, platelet-activating factor, and 5-HETE. |
1985 |
J. Cell. Physiol. |
pmid:2981891
|
Khan SN et al. |
Desaggregation of PAF-acether-aggregated platelets by verapamil and TMB-8 with reversal of phosphorylation of 40K and 20K proteins. |
1985 |
Eur. J. Pharmacol. |
pmid:3920056
|
Wasserman SI |
The mast cell and theophylline in asthma. |
1985 |
Am. J. Med. |
pmid:3002176
|
Bushfield M et al. |
Inhibition of platelet-activating-factor-induced human platelet activation by prostaglandin D2. Differential sensitivity of platelet transduction processes and functional responses to inhibition by cyclic AMP. |
1985 |
Biochem. J. |
pmid:3002327
|
O'Neill C et al. |
Maternal recognition of pregnancy prior to implantation: methods for monitoring embryonic viability in vitro and in vivo. |
1985 |
Ann. N. Y. Acad. Sci. |
pmid:2409860
|
Sage SO and Rink TJ |
Inhibition by forskolin of cytosolic calcium rise, shape change and aggregation in quin2-loaded human platelets. |
1985 |
FEBS Lett. |
pmid:2410292
|
Grandel KE et al. |
Association of platelet-activating factor with primary acquired cold urticaria. |
1985 |
N. Engl. J. Med. |
pmid:2410790
|
Bussolino F et al. |
Alkyl-ether phosphoglycerides influence calcium fluxes into human endothelial cells. |
1985 |
J. Immunol. |
pmid:2411812
|
Johnson HM and Torres BA |
Mechanism of calcium ionophore A23187-induced priming of bone marrow-derived macrophages for tumor cell killing: relationship to priming by interferon. |
1985 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:2412225
|
Tou J |
Platelet-activating factor promotes arachidonate incorporation into phosphatidylinositol and phosphatidylcholine in neutrophils. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:3921017
|
Fjellner B and Hägermark O |
Experimental pruritus evoked by platelet activating factor (PAF-acether) in human skin. |
1985 |
Acta Derm. Venereol. |
pmid:2416164
|
Shen TY et al. |
Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects. |
1985 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:2983307
|
Avdonin PV and Altukhova IP |
[Blocking with phorbol ester, a protein kinase C activator, of receptor-dependent platelet calcium channels]. |
1985 |
Biokhimiia |
pmid:2416359
|
Pannocchia A and Hardisty RM |
Cyclic AMP inhibits platelet activation independently of its effect on cytosolic free calcium. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:2983714
|
Avdonin PV et al. |
[Mechanism of increase in Ca2+ level in platelet cytoplasm induced by aggregating factors]. |
1985 |
Biokhimiia |
pmid:3000463
|
Lee TD et al. |
Heterogeneity in mast cell populations. |
1985 |
Clin Immunol Rev |
pmid:2417770
|
Leclercq M et al. |
[Effects of Hymenoptera stings: physiopathology and immunology according to recent literature findings]. |
1985 |
Rev Med Liege |
pmid:2418479
|
Pipili E |
Platelet membrane potential: simultaneous measurement of diSC3(5) fluorescence and optical density. |
1985 |
Thromb. Haemost. |
pmid:2418525
|
Nishihira J et al. |
Purification and characterization of the specific binding protein for platelet activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) from human platelets. |
1985 |
Tohoku J. Exp. Med. |
pmid:3001971
|
Cox CP et al. |
VIP elevates platelet cyclic AMP (cAMP) levels and inhibits in vitro platelet activation induced by platelet-activating factor (PAF). |
1984 Mar-Apr |
Peptides |
pmid:6206481
|
Vemulapalli S et al. |
Cardiovascular and renal action of platelet-activating factor in anesthetized dogs. |
1984 Jul-Aug |
Hypertension |
pmid:6378787
|
Wodzinowska B and Krajewski T |
[Role of blood platelets and their membrane in the process of hemostasis]. |
1984 Jan-Feb |
Postepy Hig Med Dosw |
pmid:6093087
|
Knauer KA et al. |
Platelet augmentation of IgE-dependent histamine release from human basophils and mast cells. |
1984 |
Int. Arch. Allergy Appl. Immunol. |
pmid:6200443
|
Kazimierczak W et al. |
Deuterium-oxide-induced histamine release from basophils of allergic subjects. I. Responsiveness to deuterium oxide requires an activation step. |
1984 |
Am. Rev. Respir. Dis. |
pmid:6201094
|
Fouque F and Vargaftig BB |
Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation. |
1984 |
Br. J. Pharmacol. |
pmid:6439269
|
Karlsson G and Pipkorn U |
Effect of disodium chromoglycate on changes in nasal airway resistance induced by platelet activating factor. |
1984 |
Eur. J. Clin. Pharmacol. |
pmid:6439565
|
Doebber TW et al. |
Platelet activating factor intravenous infusion in rats stimulates vascular lysosomal hydrolase secretion independent of blood neutrophils. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6517949
|
Heinrich J and Zimmermann RE |
Compound 48/80 is a potent inhibitor of human platelet aggregation antagonizing the calmodulin-dependent platelet reaction in vitro. |
1984 |
Thromb. Res. |
pmid:6523451
|
Albert DH and Snyder F |
Release of arachidonic acid from 1-alkyl-2-acyl-sn-glycero-3-phosphocholine, a precursor of platelet-activating factor, in rat alveolar macrophages. |
1984 |
Biochim. Biophys. Acta |
pmid:6435681
|
Lüthje J and Ogilvie A |
Diadenosine triphosphate (Ap3A) mediates human platelet aggregation by liberation of ADP. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6704102
|
Clare KA and Scrutton MC |
The role of Ca2+ uptake in the response of human platelets to adrenaline and to 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor). |
1984 |
Eur. J. Biochem. |
pmid:6705791
|
Pelczar-Wissner CJ et al. |
Absence of platelet activating factor (PAF) mediated platelet aggregation: a new platelet defect. |
1984 |
Am. J. Hematol. |
pmid:6720685
|